In 2012, the current solvency of drug and medical devices was 1.06 this company shows are 1.06 and circulation guaranteed for 1 contract to term creditors. This indicator shows the relative solvency guarantees and influence grew to the profitability of the company. Come 2014, this ratio increased slightly to 1.07, the company retains the attractive levels were the creditors however the affect the profitability of the company even more. As such, through the target current liquidity we see ability to pay short-term debts with the company's short-term assets remains very well and shows the company has invested relatively straight on short-term assets relative to the needs of the business, liquidity will still be guaranteed and influence grew to the profitability of the company.
đang được dịch, vui lòng đợi..
